CAROLINE ONISCHAK: Open Payments
NPI 1285976936 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 48 payments from 15 companies in 2025. Trend: 2023 $518 · 2024 $574 · 2025 $1,753
Food & beverage: $1,753
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 5 | $564 |
| ABBVIE INC. | 11 | $361 |
| Alkermes, Inc. | 3 | $188 |
| Supernus Pharmaceuticals, Inc. | 5 | $110 |
| Corium, LLC | 5 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| Tris Pharma Inc | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $34 |
Products named: SPRAVATO, VRAYLAR, ARISTADA, Qelbree, Azstarys, CAPLYTA, Dyanavel XR, REXULTI.
Industry payments across IL — which companies pay providers there.
